CDC20 facilitates the proliferation of esophageal carcinoma cell by stabilizing NLRP3 expression

Ruirui GUAN; Qian HAO; Yaqi ZHANG; Qinggang SUN; Yitian CHEN; Xiumin LI; Xiang ZHOU; Tao HAN

doi:10.19401/j.cnki.1007-3639.2024.05.004

您当前的位置：

首页 >

文章列表页 >

CDC20 facilitates the proliferation of esophageal carcinoma cell by stabilizing NLRP3 expression

Article | 更新时间：2025-12-31

- CDC20 facilitates the proliferation of esophageal carcinoma cell by stabilizing NLRP3 expression
- China Oncology Vol. 34, Issue 5, Pages: 473-484(2024)
- 作者机构：
  
  1. 新乡医学院健康中原研究院，新乡市分子癌学重点实验室，河南新乡 453003
  2. 新乡医学院第三附属医院消化内科，河南新乡 453003
  3. 复旦大学附属肿瘤医院肿瘤研究所，复旦大学上海医学院肿瘤学系，上海 200032
  4. 新乡医学院基础医学院，河南新乡 453003
  5. 新乡医学院第一附属医院消化内科，河南新乡 453003
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2024.05.004
  CLC： R735.1
- Received：27 December 2023，
  
  Revised：2024-03-06，
  
  Published：30 May 2024
- 稿件说明：
移动端阅览
Ruirui GUAN, Qian HAO, Yaqi ZHANG, et al. CDC20 facilitates the proliferation of esophageal carcinoma cell by stabilizing NLRP3 expression[J]. China Oncology, 2024, 34(5): 473-484.
DOI：

Ruirui GUAN, Qian HAO, Yaqi ZHANG, et al. CDC20 facilitates the proliferation of esophageal carcinoma cell by stabilizing NLRP3 expression[J]. China Oncology, 2024, 34(5): 473-484. DOI： 10.19401/j.cnki.1007-3639.2024.05.004.

摘要

背景与目的：

食管癌（esophageal carcinoma，ESCA）是死亡率较高的恶性肿瘤之一，其发生、发展的机制不明。

CDC

20被认为具有癌基因功能，其表达失调与肿瘤的发生、发展密切相关。CDC20在多种肿瘤中表达升高，敲低CDC20能够抑制肿瘤细胞增殖。NLRP3是炎症小体的主要成分之一，炎症小体失调与肿瘤的发生、发展也密切相关。本研究旨在探究CDC20是否通过NLRP3促进ESCA细胞增殖，同时分析其调控机制。

方法：

通过癌症基因组图谱（The Cancer Genome Atlas，TCGA）数据库和GTEx公共数据库分析ESCA患者中

CDC

20和

NLRP

3基因的表达水平。收集新乡医学院第一附属医院收治的80例ESCA患者的临床病理学资料和组织，通过免疫组织化学染色检测NLRP3在ESCA患者中的蛋白表达水平。本研究通过新乡医学院第一附属医院伦理委员会的审批（编号：EC-021-137）。通过短发夹RNA（short hairpin RNA，shRNA）技术检测敲低

CDC

20和

NLRP

3基因后对食管鳞状细胞癌细胞系EC9706和KYSE150增殖能力的影响。通过免疫共沉淀（Co-immunoprecipitation，Co-IP）、蛋白酶体抑制剂和泛素化实验检测CDC20是否与NLRP3相互作用，以及阐明CDC20是否通过泛素化途径调控NLRP3表达。

结果：

TCGA数据库分析结果显示，ESCA组织中CDC20和NLRP3 mRNA表达水平明显高于癌旁组织。免疫组织化学结果也进一步显示，与癌旁组织相比，CDC20、NLRP3在ESCA组织中蛋白表达水平升高。敲低

CDC

20和

NLRP

3基因可抑制ESCA细胞增殖。Co-IP、蛋白酶体抑制剂和泛素化实验证实CDC20通过NLRP3的LRR区与NLRP3相互作用，且CDC20通过促进NLRP3泛素化稳定其表达。

结论：

CDC20和NLRP3在ESCA癌组织中表达上调，且CDC20通过泛素化NLRP3稳定其表达，从而促进ESCA细胞增殖，提示CDC20和NLRP3可能是ESCA潜在的诊断靶向标志物。

Abstract

Background and purpose:

Esophageal carcinoma (ESCA) is one of the malignant tumors with high mortality rate

and the underlying mechanism of its development is largely unknown.

CDC

20 plays an important role in tumorigenesis

and its dysregulated expression is closely related to tumor occurrence and development. The expression of CDC20 is increased in a variety of tumors

and knocking down

CDC

20 can inhibit tumor cell proliferation. NLRP3 is the main component of the inflammasome

and inflammasome is also closely related to tumor occurrence and development. Here

our study aimed to investigate whether CDC20 promotes the proliferation of ESCA cells through NLRP3 and its regulatory mechanism

Methods:

The expression levels of

CDC

20 and

NLRP

3 genes in ESCA patients were analyzed using The Cancer Genome Atlas (TCGA) detabase and GTEx public database. We collected clinical and pathological data and tissues from 80 ESCA patients at the First Affiliated Hospital of Xinxiang Medical College

and detected the protein expression of NLRP3 in ESCA patients through immunohistochemistry staining. This study was approved by the Ethics Committee of the First Affiliated Hospital of Xinxiang Medical College (Number: EC-021-137). We studied the effects of knocking down

CDC

20 and

NLRP

3 gene on the proliferation ability of esophageal squamous cell carcinoma cells EC9706 and KYSE150 using short hairpin RNA (shRNA) technology. Co-immunoprecipitation (Co-IP)

proteasome inhibitors and ubiquitination experiments were used to detect whether CDC20 interacts with NLRP3

and to elucidate whether CDC20 regulates NLRP3 expression through the ubiquitination pathway. This study was approved by the Ethics Committee of the First Affiliated Hospital of Xinxiang Medical College (Number: EC-021-137).

Results:

The TCGA database analysis showed that the expression levels of CDC20 and NLRP3 mRNA were significantly higher in the cancer tissues of ESCA patients than in the adjacent tissues. The immunohistochemistry results further showed that compared with adjacent tissues

the protein expression levels of CDC20 and NLRP3 were increased in ESCA tissues. Knocking down

CDC

20 and

NLRP

3 genes inhibited the proliferation of ESCA cells. Co-IP

proteasome inhibitors and ubiquitination experiments confirmed that CDC20 interacted with NLRP3 through its leucine-rich repeat (LRR)

and CDC20 stabilized its expression by promoting NLRP3 ubiquitination.

Conclusion:

CDC20 and NLRP3 are upregulated in ESCA tissues

and CDC20 stabilizes their expression through ubiquitination of NLRP3

promoting ESCA cell proliferatio

n. This suggests that CDC20 and NLRP3 may be potential diagnostic targets for ESCA.

关键词

Keywords

references

FATEHI HASSANABAD A , CHEHADE R , BREADNER D , et al. Esophageal carcinoma: towards targeted therapies [J ] . Cell Oncol , 2020 , 43 ( 2 ): 195 - 209 .

ZHANG Y W . Epidemiology of esophageal cancer [J ] . World J Gastroenterol , 2013 , 19 ( 34 ): 5598 - 5606 .

SAEI GHARE NAZ M , KARIMAN N , EBADI A , et al. Educational interventions for cervical cancer screening behavior of women: a systematic review [J ] . Asian Pac J Cancer Prev , 2018 , 19 ( 4 ): 875 - 884 .

CHEN W Q , ZHENG R S , BAADE P D , et al. Cancer statistics in China, 2015 [J ] . CA Cancer J Clin , 2016 , 66 ( 2 ): 115 - 132 .

HAN T , JIANG S L , ZHENG H , et al. Interplay between c-Src and the APC/C co-activator Cdh1 regulates mammary tumorigenesis [J ] . Nat Commun , 2019 , 10 ( 1 ): 3716.

WAN L X , CHEN M , CAO J X , et al. The APC/C E3 ligase complex activator FZR1 restricts BRAF oncogenic function [J ] . Cancer Discov , 2017 , 7 ( 4 ): 424 - 441 .

HUANG H C , SHI J , ORTH J D , et al. Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly [J ] . Cancer Cell , 2009 , 16 ( 4 ): 347 - 358 .

MANCHADO E , GUILLAMOT M , DE CÁRCER G , et al. Targeting mitotic exit leads to tumor regression in vivo : modulation by Cdk1, Mastl, and the PP2A/B55α, δ phosphatase [J ] . Cancer Cell , 2010 , 18 ( 6 ): 641 - 654 .

ZHANG Q , HUANG H , LIU A , et al. Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells [J ] . EBioMedicine , 2019 , 42 : 397 - 407 . DOI: S2352-3964(19)30172-0 http://doi.org/S2352-3964(19)30172-0

KARRA H , REPO H , AHONEN I , et al. CDC20 and securin overexpression predict short-term breast cancer survival [J ] . Br J Cancer , 2014 , 110 ( 12 ): 2905 - 2913 .

JI P , SMITH S M , WANG Y , et al. Inhibition of gliomagenesis and attenuation of mitotic transition by MIIP [J ] . Oncogene , 2010 , 29 ( 24 ): 3501 - 3508 . DOI: 10.1038/onc.2010.114 http://doi.org/10.1038/onc.2010.114

KIM J M , SOHN H Y , YOON S Y , et al. Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells [J ] . Clin Cancer Res , 2005 , 11 (2 Pt 1 ): 473 - 482 .

XIE Q , WU Q L , MACK S C , et al. CDC20 maintains tumor initiating cells [J ] . Oncotarget , 2015 , 6 ( 15 ): 13241 - 13254 .

JIANG J H , JEDINAK A , SLIVA D . Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA [J ] . Biochem Biophys Res Commun , 2011 , 415 ( 2 ): 325 - 329 .

HE S D , LIU D P , CHEN Z H . REC8 inhibits proliferation, migration and invasion of breast cancer cells by targeting CDC20 [J ] . Mol Med Rep , 2022 , 26 ( 1 ): 235.

PAUL D , GHORAI S , DINESH U S , et al. CDC20 directs proteasome-mediated degradation of the tumor suppressor SMAR1 in higher grades of cancer through the anaphase promoting complex [J ] . Cell Death Dis , 2017 , 8 ( 6 ): e2882.

YANG G , WANG G , XIONG Y F , et al. CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial-mesenchymal transition [J ] . Mol Med Rep , 2021 , 24 ( 1 ): 483.

MARUCCI G , MORANDI L , MAGRINI E , et al. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20 [J ] . Virchows Arch , 2008 , 453 ( 6 ): 599 - 609 . DOI: 10.1007/s00428-008-0685-7 http://doi.org/10.1007/s00428-008-0685-7

OUELLET V , GUYOT M C , PAGE C L , et al. Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer [J ] . Int J Cancer , 2006 , 119 ( 3 ): 599 - 607 .

SAGOO P , GARCIA Z , BREART B , et al. In vivo imaging of inflammasome activation reveals a subcapsular macrophage burst response that mobilizes innate and adaptive immunity [J ] . Nat Med , 2016 , 22 ( 1 ): 64 - 71 .

HE Y , HARA H , NÚÑEZ G . Mechanism and regulation of NLRP3 inflammasome activation [J ] . Trends Biochem Sci , 2016 , 41 ( 12 ): 1012 - 1021 . DOI: S0968-0004(16)30148-7 http://doi.org/S0968-0004(16)30148-7

THI H T H , HONG S . Inflammasome as a therapeutic target for cancer prevention and treatment [J ] . J Cancer Prev , 2017 , 22 ( 2 ): 62 - 73 . DOI: 10.15430/JCP.2017.22.2.62 http://doi.org/10.15430/JCP.2017.22.2.62

GRIVENNIKOV S I , GRETEN F R , KARIN M . Immunity, inflammation, and cancer [J ] . Cell , 2010 , 140 ( 6 ): 883 - 899 . DOI: 10.1016/j.cell.2010.01.025 http://doi.org/10.1016/j.cell.2010.01.025

PEI H P , TAN F B , LIU L , et al. IL-1β/NF-kb signaling promotes colorectal cancer cell growth through miR-181a/PTEN axis [J ] . Arch Biochem Biophys , 2016 , 604 : 20 - 26 . DOI: 10.1016/j.abb.2016.06.001 http://doi.org/10.1016/j.abb.2016.06.001

BAE J Y , LEE S W , SHIN Y H , et al. P2X7 receptor and NLRP3 inflammasome activation in head and neck cancer [J ] . Oncotarget , 2017 , 8 ( 30 ): 48972 - 48982 . DOI: 10.18632/oncotarget.16903 http://doi.org/10.18632/oncotarget.16903

SIEGEL R , MA J , ZOU Z , et al. Cancer statistics, 2014 [J ] . CA Cancer J Clin , 2014 , 64 ( 1 ): 9 - 29 .

WANG W B , XIAO F , WAN P , et al. EV71 3D protein binds with NLRP3 and enhances the assembly of inflammasome complex [J ] . PLoS Pathog , 2017 , 13 ( 1 ): e1006123.

GUARDA G , ZENGER M , YAZDI A S , et al. Differential expression of NLRP3 among hematopoietic cells [J ] . J Immunol , 2011 , 186 ( 4 ): 2529 - 2534 . DOI: 10.4049/jimmunol.1002720 http://doi.org/10.4049/jimmunol.1002720

GWYER FINDLAY E , HUSSELL T . Macrophage-mediated inflammation and disease: a focus on the lung [J ] . Mediators Inflamm , 2012 , 2012 : 140937 .

BRAY F , FERLAY J , SOERJOMATARAM I , et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2018 , 68 ( 6 ): 394 - 424 .

YU S , YIN J J , MIAO J X , et al. Activation of NLRP3 inflammasome promotes the proliferation and migration of esophageal squamous cell carcinoma [J ] . Oncol Rep , 2020 , 43 ( 4 ): 1113 - 1124 . DOI: 10.3892/or.2020.7493 http://doi.org/10.3892/or.2020.7493

ALIDINA A , SIDDIQUI T , BURNEY I , et al. Esophageal cancer: a review [J ] . J Pak Med Assoc , 2004 , 54 ( 3 ): 136 - 141 .

MIMURA K , YAMADA L , UJIIE D , et al. Immunotherapy for esophageal squamous cell carcinoma: a review [J ] . Fukushima J Med Sci , 2018 , 64 ( 2 ): 46 - 53 . DOI: 10.5387/fms.2018-09 http://doi.org/10.5387/fms.2018-09

SAYAN M , MOSSMAN B T . The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases [J ] . Part Fibre Toxicol , 2016 , 13 ( 1 ): 51.

CAO Z W , FANG Y L , LU Y H , et al. Exposure to nickel oxide nanoparticles induces pulmonary inflammation through NLRP3 inflammasome activation in rats [J ] . Int J Nanomedicine , 2016 , 11 : 3331 - 3346 .

吕本洁 , 周孝峰 , 王伟隆 , 等 . 食管鳞癌组织Snail与PDL-1和CD8 + T表达及预后分析 [J ] . 中华肿瘤防治杂志 , 2023 , 30 ( 2 ): 78 - 83 .

LYU B J , ZHOU X F , WANG W L , et al. Correlation and prognostic analysis of Snail with PD-L1 and CD8 + T in esophageal squamous cell carcinoma [J ] . Chin J Cancer Prev Treat , 2023 , 30 ( 2 ): 78 - 83 .

GOMES-SANTOS I L , AMOOZGAR Z , KUMAR A S , et al. Exercise training improves tumor control by increasing CD8 + T-cell infiltration via CXCR3 signaling and sensitizes breast cancer to immune checkpoint blockade [J ] . Cancer Immunol Res , 2021 , 9 ( 7 ): 765 - 778 .

Views

1798

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

TIPE regulates glucometabolic reprogramming by modulating LDHA expression in triple-negative breast cancer

Mechanistic study on PLK4 regulation of invasion, proliferation and apoptosis in oral squamous cell carcinoma

PARP1 promotes the progression of hepatocellular carcinoma by regulating expression of POU2F2

Effects of TMCO1 on proliferation and migration of cervical cancer cells

PRMT7 inhibits proliferation and migration of bladder cancer cells by regulating Notch signaling pathway

Related Author

Wei HU

Xiaomeng REN

Yang WANG

Peiqing ZHAO

Kai CAO

Huan QIN

Jie WANG

Jie YANG

Related Institution

Department of Breast Surgery, Zibo Central Hospital

Department of Central Laboratory, Zibo Central Blood Station

Department of Clinical Laboratory, Huantai County People’s Hospital

Translational Medical Center, Zibo Central Hospital

Department of Pharmacy, Zibo Central Hospital

AI问答

⁰